These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35266065)

  • 1. Compassionate use of Quantum Magnetic Resonance Therapy for treatment of children with Diffuse Brainstem Glioma in Mexico City: a single institutional experience.
    Barragán-Pérez EJ; Alvarez-Amado DE; Dies-Suarez P; Tobón SH; García-Beristain JC; Peñaloza-González JG
    J Neurooncol; 2022 Apr; 157(2):377-382. PubMed ID: 35266065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
    Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
    Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy.
    Patay Z; Merchant TE; Nguyen R; Pierson CR; Onar-Thomas A; Broniscer A
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1295-1305. PubMed ID: 29165288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2019 Mar; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
    McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
    J Neurosurg Pediatr; 2021 Oct; 28(4):371-379. PubMed ID: 34359048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
    Pollack IF; Stewart CF; Kocak M; Poussaint TY; Broniscer A; Banerjee A; Douglas JG; Kun LE; Boyett JM; Geyer JR
    Neuro Oncol; 2011 Mar; 13(3):290-7. PubMed ID: 21292687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of
    Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
    J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modality of Radiotherapy and Overall Survival in Pediatric Diffuse Brainstem Gliomas: Implications for Resource-Constrained Settings.
    Rasool MT; Dar IA; Banday SZ; Banday AZ; Chibber SS; Choh NA; Baba MH; Lone MM
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33280037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.
    Chiang KL; Chang KP; Lee YY; Huang PI; Hsu TR; Chen YW; Chang FC; Wong TT
    Childs Nerv Syst; 2010 Aug; 26(8):1035-41. PubMed ID: 20217098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
    Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
    Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation among magnetic resonance imaging findings, prognostic factors for survival, and histological diagnosis of intrinsic brainstem lesions in children.
    Dellaretti M; Touzet G; Reyns N; Dubois F; Gusmão S; Pereira JL; Blond S
    J Neurosurg Pediatr; 2011 Dec; 8(6):539-43. PubMed ID: 22132909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.
    Tisnado J; Young R; Peck KK; Haque S
    J Child Neurol; 2016 Oct; 31(12):1386-93. PubMed ID: 27071471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
    Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
    Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
    Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
    Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
    Ohno M; Natsume A; Fujii M; Ito M; Wakabayashi T
    Pediatr Blood Cancer; 2009 Jul; 53(1):37-41. PubMed ID: 19260101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
    Hennika T; Becher OJ
    J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
    Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
    Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.
    Ceschin R; Kocak M; Vajapeyam S; Pollack IF; Onar-Thomas A; Dunkel IJ; Poussaint TY; Panigrahy A
    J Neurooncol; 2019 May; 143(1):79-86. PubMed ID: 30810873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma.
    Jackson S; Patay Z; Howarth R; Pai Panandiker AS; Onar-Thomas A; Gajjar A; Broniscer A
    J Neurooncol; 2013 Sep; 114(3):339-44. PubMed ID: 23813229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
    Poussaint TY; Kocak M; Vajapeyam S; Packer RI; Robertson RL; Geyer R; Haas-Kogan D; Pollack IF; Vezina G; Zimmerman R; Cha S; Patay Z; Boyett JM; Kun LE
    Neuro Oncol; 2011 Apr; 13(4):417-27. PubMed ID: 21297126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.